Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Vemurafenib Soft Tissue Sarcoma	OHSU Knight Cancer Institute	P2	B (59)
Venetoclax Hematopoietic And Lymphoid Cell Neoplasm	University of Alabama at Birmingham	P2	B (59)
(+)-Vincristine Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	B (59)
(+)-Vincristine T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P2	B (59)
Vismodegib Ovarian Carcinoma	OHSU Knight Cancer Institute	P2	B (59)
Vismodegib Prostate Carcinoma	OHSU Knight Cancer Institute	P2	B (59)
Vismodegib Non-Hodgkin Lymphoma	OHSU Knight Cancer Institute	P2	B (59)
Vismodegib Hematopoietic And Lymphoid System Neoplasm	Helsinki University Central Hospital	P2	B (59)
XENON Pulmonary Fibrosis	Duke University	P2	B (59)
Zanidatamab Gastric Cancer	Jazz Pharmaceuticals	P2	B (59)
Zimberelimab Triple-Negative Breast Carcinoma	MedSIR	P2	B (59)
Ziv-Aflibercept Metastatic Melanoma	National Cancer Institute (NCI)	P2	B (59)
11.BETA.,13-DIHYDRO-13-(DIMETHYLAMINO)MICHELIOLIDE Glioblastoma	National Neuroscience Institute	P2	B (58)
1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER Alzheimer Disease	Fondation Ophtalmologique Adolphe de Rothschild	P2	B (58)
17b-estradiol Breast Cancer	Mary D Chamberlin	P2	B (58)
18f-flt Breast Carcinoma	University of Washington	P2	B (58)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Multiple Sclerosis	Alta Bates Summit Medical Center	P2	B (58)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Parkinson Disease	VA Office of Research and Development	P2	B (58)
4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE Dementia	Akiva Mintz	P2	B (58)
Abatacept Recombinant Graft Versus Host Disease	Emory University	P2	B (58)
Abemaciclib Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	P2	B (58)
Adagrasib Cancer	Bristol-Myers Squibb	P2	B (58)
Adagrasib Metastatic Malignant Neoplasm	Mirati Therapeutics Inc.	P2	B (58)
Adavosertib Ovarian Carcinoma	M.D. Anderson Cancer Center	P2	B (58)
Adriamycin Ewing Sarcoma	Children's National Research Institute	P2	B (58)

Showing 2451 to 2475 of 13,155 assets

PreviousPage 99 of 527Next